Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcome
- 1 May 2014
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 182, 58-66
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicityBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Molecularly targeted therapies for metastatic triple-negative breast cancerBreast Cancer Research and Treatment, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostatBreast Cancer Research, 2012
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of actionBreast Cancer Research, 2011
- HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab TrialJournal of Clinical Oncology, 2010
- Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGelPLOS ONE, 2009
- Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding SiteJournal of Molecular Biology, 1996
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987